Quantitative imaging of lymphatic function with liposomal indocyanine green.
Lymphatic vessels play a major role in cancer progression and in postsurgical lymphedema, and several new therapeutic approaches targeting lymphatics are currently being developed. Thus, there is a critical need for quantitative imaging methods to measure lymphatic flow. Indocyanine green (ICG) has been used for optical imaging of the lymphatic system, but it is unstable in solution and may rapidly enter venous capillaries after local injection. We developed a novel liposomal formulation of ICG (LP-ICG), resulting in vastly improved stability in solution and an increased fluorescence signal with a shift toward longer wavelength absorption and emission. When injected intradermally to mice, LP-ICG was specifically taken up by lymphatic vessels and allowed improved visualization of deep lymph nodes. In a genetic mouse model of lymphatic dysfunction, injection of LP-ICG showed no enhancement of draining lymph nodes and slower clearance from the injection site. In mice bearing B16 luciferase-expressing melanomas expressing vascular endothelial growth factor-C (VEGF-C), sequential near-IR imaging of intradermally injected LP-ICG enabled quantification of lymphatic flow. Increased flow through draining lymph nodes was observed in mice bearing VEGF-C-expressing tumors without metastases, whereas a decreased flow pattern was seen in mice with a higher lymph node tumor burden. This new method will likely facilitate quantitative studies of lymphatic function in preclinical investigations and may also have potential for imaging of lymphedema or improved sentinel lymph detection in cancer.
Proulx
Steven T
ST
Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland.
Luciani
Paola
P
Derzsi
Stefanie
S
Rinderknecht
Matthias
M
Mumprecht
Viviane
V
Leroux
Jean-Christophe
JC
Detmar
Michael
M
D000818:Animals; D004396:Coloring Agents / Q000008:administration & dosage; D007208:Indocyanine Green / Q000008:administration & dosage; D007271:Injections, Intradermal; D008081:Liposomes / Q000008:administration & dosage; D008207:Lymphatic Metastasis; D042601:Lymphatic Vessels / Q000378:metabolism / Q000473:pathology*; D008546:Melanoma, Experimental / Q000098:blood supply / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D042582:Vascular Endothelial Growth Factor C / Q000096:biosynthesis
D004396:Coloring Agents; D008081:Liposomes; D042582:Vascular Endothelial Growth Factor C; C467483:vascular endothelial growth factor C, mouse; D007208:Indocyanine Green
J Cell Mol Med. 2009 Aug;13(8A):1405-16
19583813
Cell Tissue Res. 2009 Jan;335(1):97-108
18648856
Cancer Res. 2006 Aug 15;66(16):8065-75
16912183
Mol Imaging. 2005 Jul-Sep;4(3):172-81
16194449
Curr Opin Biotechnol. 2007 Feb;18(1):17-25
17234399
Cancer Res. 2007 Sep 1;67(17):8223-8
17804736
Am J Pathol. 2007 Feb;170(2):774-86
17255343
Mol Pharm. 2009 Mar-Apr;6(2):480-91
19228053
J Immunol Methods. 2006 May 30;312(1-2):12-9
16624319
J Exp Med. 2005 Apr 4;201(7):1089-99
15809353
Breast J. 2002 Jul-Aug;8(4):192-8
12100110
Blood. 2007 Feb 1;109(3):1010-7
17032920
Trends Biotechnol. 1998 Jul;16(7):307-21
9675915
Contrast Media Mol Imaging. 2006 Nov-Dec;1(6):230-45
17191764
Nat Med. 2001 Feb;7(2):192-8
11175850
Curr Opin Biotechnol. 2009 Feb;20(1):74-82
19233639
Int J Pharm. 2004 Jul 8;278(2):293-301
15196634
Annu Rev Pathol. 2008;3:367-97
18039141
Biochim Biophys Acta. 1991 Nov 18;1070(1):187-92
1751525
J Immunol Methods. 2008 Mar 20;332(1-2):170-4
18164026
Cancer Res. 2001 Mar 1;61(5):1786-90
11280723
Radiology. 1989 Aug;172(2):315-7
2748809
Ann N Y Acad Sci. 2008;1131:13-36
18519956
Biochim Biophys Acta. 1985 Jan 10;812(1):55-65
23008845
J Chromatogr B Biomed Sci Appl. 1999 Jun 11;729(1-2):55-64
10410927
Clin Cancer Res. 2008 May 15;14(10):2944-52
18483361
Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H3109-18
17307997
Eur J Vasc Endovasc Surg. 2008 Aug;36(2):230-6
18534875
Cancer Res. 2003 Jan 15;63(2):271-6
12543772
J Control Release. 2006 Apr 10;111(3):343-51
16490277
BMC Cancer. 2009 Oct 12;9:362
19821979
Breast J. 2005 May-Jun;11(3):188-94
15871704
J Clin Invest. 1960 Apr;39:592-600
13809697
J Pharm Sci. 2003 Oct;92(10):2090-7
14502548
Curr Opin Chem Biol. 2003 Oct;7(5):626-34
14580568
Adv Drug Deliv Rev. 2001 Aug 23;50(1-2):143-56
11489337
Oncogene. 2005 Aug 18;24(35):5510-20
15897888
Ann Surg Oncol. 2006 Dec;13(12):1671-81
17009138
Magn Reson Med. 2002 Feb;47(2):292-7
11810672
AJR Am J Roentgenol. 2002 Dec;179(6):1567-72
12438057
Int J Cancer. 2002 Apr 20;98(6):946-51
11948478
Microvasc Res. 1998 Mar;55(2):146-52
9521889
Eur J Radiol. 2006 Jun;58(3):375-82
16464554
J Physiol. 2006 Jul 15;574(Pt 2):583-96
16675495
Bioconjug Chem. 2004 Jan-Feb;15(1):79-86
14733586